Does Long-Term HIV Therapy Cut Anogenital Cancer Risk?
|
A study in Botswana finds that long-term antiretroviral
therapy does not appear to lower the risk for anogenital cancer among people
living with ... |
NICE rejects long-acting HIV prevention treatment for NHS use
Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...